Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 5;16(12):1689.
doi: 10.3390/ph16121689.

Drug Safety and Relevant Issues in the Real-World

Maria Antonietta Barbieri  1 , Natasha Irrera  1 , Irma Convertino  2
Affiliations
Editorial

Drug Safety and Relevant Issues in the Real-World

Maria Antonietta Barbieri et al. Pharmaceuticals (Basel). .

Abstract

The global impact of the COVID-19 pandemic has underscored the pivotal role of drug safety and effective communication within the realm of pharmacovigilance, particularly in times of unprecedented public health emergencies [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Chandler R.E., McCarthy D., Delumeau J.C., Harrison-Woolrych M. The Role of Pharmacovigilance and ISoP during the Global COVID-19 Pandemic. Drug Saf. 2020;43:511–512. doi: 10.1007/s40264-020-00941-4. - DOI - PMC - PubMed
    1. Kim H.-S., Lee S., Kim J.H. Real-World Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records. J. Korean Med. Sci. 2018;33:e213. doi: 10.3346/jkms.2018.33.e213. - DOI - PMC - PubMed
    1. Tan Y.Y., Papez V., Chang W.H., Mueller S.H., Denaxas S., Lai A.G. Comparing Clinical Trial Population Representativeness to Real-World Populations: An External Validity Analysis Encompassing 43,895 Trials and 5,685,738 Individuals across 989 Unique Drugs and 286 Conditions in England. Lancet Healthy Longev. 2022;3:e674–e689. doi: 10.1016/S2666-7568(22)00186-6. - DOI - PubMed
    1. Purpura C.A., Garry E.M., Honig N., Case A., Rassen J.A. The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications. Clin. Pharmacol. Ther. 2022;111:135–144. doi: 10.1002/cpt.2474. - DOI - PMC - PubMed
    1. Blonde L., Khunti K., Harris S.B., Meizinger C., Skolnik N.S. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician. Adv. Ther. 2018;35:1763–1774. doi: 10.1007/s12325-018-0805-y. - DOI - PMC - PubMed

Publication types

LinkOut - more resources